Number of the records: 1
Outcome of Treatment of Human HeLa Cervical Cancer Cells With Roscovitine Strongly Depends on the Dosage and Cell Cycle Status Prior to the Treatment
- 1.0337483 - ÚEB 2010 RIV US eng J - Journal Article
Wesierska-Gadek, J. - Borza, A. - Walzi, E. - Kryštof, Vladimír - Maurer, M. - Komina, O. - Wandl, S.
Outcome of Treatment of Human HeLa Cervical Cancer Cells With Roscovitine Strongly Depends on the Dosage and Cell Cycle Status Prior to the Treatment.
Journal of Cellular Biochemistry. Roč. 106, č. 5 (2009), s. 937-955. ISSN 0730-2312. E-ISSN 1097-4644
Institutional research plan: CEZ:AV0Z50380511
Keywords : APOPTOSIS * CELL CYCLE ARREST * CYCLIN-DEPENDENT KINASES
Subject RIV: ED - Physiology
Impact factor: 2.935, year: 2009
Permanent Link: http://hdl.handle.net/11104/0181463
Number of the records: 1